InvestorsHub Logo
Followers 58
Posts 10022
Boards Moderated 1
Alias Born 09/21/2016

Re: polarbear77 post# 114310

Monday, 08/07/2017 4:08:13 PM

Monday, August 07, 2017 4:08:13 PM

Post# of 457726

[And as we all know, last November Dr Perry had this to say about Anavex's 41 week data: "Although this is an open label study with 32 patients, I have never seen mild-to-moderate Alzheimer’s patients maintain near baseline cognitive and activities of daily living function and positive correlation with all other measures over a 41-week trial period in any prior study with an approved or experimental drug. It is quite plausible that complex CNS diseases like Alzheimer’s may require a comprehensive approach, including restoration of cellular homeostasis.”
/quote]

He Shoots.....he SCORES....nice

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News